Anne Samuel
Stock Analyst at JP Morgan
(1.84)
# 3,174
Out of 5,182 analysts
67
Total ratings
50%
Success rate
-2.55%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $4.27 | +63.93% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $83.99 | +50.02% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $168.25 | +72.36% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $19.16 | +30.48% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $26.03 | +130.50% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $178.64 | -0.92% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $43.33 | -16.92% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $9.83 | +184.84% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $28.29 | -25.77% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $1.59 | +717.61% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $21.01 | +28.51% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $0.92 | +442.30% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $4.27
Upside: +63.93%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $83.99
Upside: +50.02%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $168.25
Upside: +72.36%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $19.16
Upside: +30.48%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $26.03
Upside: +130.50%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $178.64
Upside: -0.92%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $43.33
Upside: -16.92%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $9.83
Upside: +184.84%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $28.29
Upside: -25.77%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $1.59
Upside: +717.61%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $21.01
Upside: +28.51%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $0.92
Upside: +442.30%